Metabolic screening in primary care for patients with schizophrenia or schizoaffective disorder and taking antipsychotic medication
ABSTRACT INTRODUCTIONLife expectancy in patients with schizophrenia is 15-20 years less than the general population. A dominant cause of morbidity and mortality in these patients is cardiovascular disease. Adverse consequences of modifiable cardiovascular risk factors can be reduced by regular monit...
Saved in:
Main Authors: | Ross Lawrenson (Author), Sophie Scarlet (Author), Ruzaimah Mohammed (Author), Kee Ping Lim (Author), Shivam Deo (Author), Abhijit Bhat (Author), Muhammad Asim (Author), Chunhuan Lao (Author), Sally Carter (Author), Joanna Ly (Author), Lynne Chepulis (Author), Rawiri Keenan (Author) |
---|---|
Format: | Book |
Published: |
CSIRO Publishing,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The epidemiology of diabetes in the Waikato region: an analysis of primary care data
by: Ross Lawrenson, et al.
Published: (2021) -
Metformin adherence in patients with type 2 diabetes and its association with glycated haemoglobin levels
by: Ross Lawrenson, et al.
Published: (2020) -
Prevalence of invasive cancer in a large general practice patient population in New Zealand
by: Ross Lawrenson, et al.
Published: (2020) -
Switching Between Second-Generation Antipsychotics in Patients with Schizophrenia and Schizoaffective Disorder: 10-Year Cohort Study in Brazil
by: Izabela Fulone, et al.
Published: (2021) -
The structure and dynamic of the defensive organization the personality in Paranoid Schizophrenia, Schizoaffective and Affective Disorders
by: I M Kadyrov, et al.
Published: (2011)